Similar articles

• Cost-effectiveness of interferon treatment for hepatitis C.

  van Leeuwen DJ. van Leeuwen DJ. JAMA. 1999 Jun 9;281(22):2083-4. JAMA. 1999. PMID: 10367810 No abstract available.
• [Economic evaluation of combined therapy in chronic hepatitis C].

  Casado MA, Buti M, Fosbrook L, Esteban R. Casado MA, et al. Gastroenterol Hepatol. 2000 Feb;23 Suppl 1:57-62. Gastroenterol Hepatol. 2000. PMID: 11968346 Review. Spanish. No abstract available.
• [Cost-effectiveness of antiviral therapy for chronic hepatitis C patients in prevention of hepatocellular cancer ].

  Yoshida H, Tateishi R, Omata M. Yoshida H, et al. Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):511-4. Nihon Rinsho. 2004. PMID: 15359852 Japanese. No abstract available.
• Cost-effectiveness of treatment for chronic hepatitis C.

  Koff RS. Koff RS. J Hepatol. 1999;31 Suppl 1:255-8. doi: 10.1016/s0168-8278(99)80412-7. J Hepatol. 1999. PMID: 10622598 Review.
• Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.

  Chan K, Lai MN, Groessl EJ, Hanchate AD, Wong JB, Clark JA, Asch SM, Gifford AL, Ho SB. Chan K, et al. Clin Gastroenterol Hepatol. 2013 Nov;11(11):1503-10. doi: 10.1016/j.cgh.2013.05.014. Epub 2013 May 22. Clin Gastroenterol Hepatol. 2013. PMID: 23707354